Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine

Inflamm Bowel Dis. 2021 Aug 19;27(9):e110-e111. doi: 10.1093/ibd/izab106.
No abstract available

Keywords: cyclosporine; extra-intestinal complications; inflammatory bowel disease; pyoderma gangrenosum.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Child
  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / drug therapy
  • Cyclosporine / therapeutic use
  • Humans
  • Pyoderma Gangrenosum* / chemically induced
  • Pyoderma Gangrenosum* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Cyclosporine
  • vedolizumab